Neuros Medical, a Cleveland based neuromodulation company, has received approval from the FDA to start a pilot clinical trial to evaluate its high-frequency Electrical Nerve Block technology for use in acute treatment of pain in the residual limb of amputees, according to a company news release.
This test will build off a feasibility study earlier this year in which four out of five patients reported significant pain reduction. Chronic amputation pain affects one million patients in the U.S.
Related Articles on Pain Management:
American Medical Association to Help Physicians Prevent Misuse and Abuse of Prescription Opioids
Global Pain Management Therapeutics Market Sales Forecasted to Reach $35.1B by 2017
7 Recent Studies & Research Findings on Painkillers
This test will build off a feasibility study earlier this year in which four out of five patients reported significant pain reduction. Chronic amputation pain affects one million patients in the U.S.
Related Articles on Pain Management:
American Medical Association to Help Physicians Prevent Misuse and Abuse of Prescription Opioids
Global Pain Management Therapeutics Market Sales Forecasted to Reach $35.1B by 2017
7 Recent Studies & Research Findings on Painkillers